Hypersensitivity Reaction in the US Food and Drug Administration-Approved Second-Generation Drug-Eluting Stents Histopathological Assessment With Ex Vivo Optical Coherence Tomography

被引：24
|
作者：
Otsuka, Fumiyuki [1 ]
Yahagi, Kazuyuki [1 ]
Ladich, Elena [1 ]
Kutys, Robert [1 ]
Alexander, Russell [2 ]
Fowler, David [2 ]
Virmani, Renu [1 ]
Joner, Michael [1 ]
机构：
[1] CVPath Inst Inc, Gaithersburg, MD 20878 USA
[2] Off Chief Med Examiner, Baltimore, MD USA
来源：
CIRCULATION | 2015年 / 131卷 / 03期
关键词：
SIROLIMUS;
D O I：
10.1161/CIRCULATIONAHA.114.012658
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：322 / 324
页数：3
相关论文
共 50 条
  • [21] Saphenous Vein Graft Lesions: Are Second-Generation Drug-Eluting Stents Better?
    Kolte, Dhaval
    Abbott, J. Dawn
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (01) : 41 - 42
  • [22] In vitro evaluation of second-generation drug-eluting coronary stents with 256-slice computed tomography
    Kuga, Y.
    Yoshimura, K.
    Ueda, H.
    Kido, A.
    Matsuhisa, S.
    Asawa, K.
    Yoshida, N.
    Yamasaki, M.
    Ueda, K.
    Nishida, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 973 - 974
  • [23] Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation. An Optical Coherence Tomography Study
    Jinnouchi, Hiroyuki
    Kuramitsu, Shoichi
    Shinozaki, Tomohiro
    Tomoi, Yusuke
    Hiromasa, Takashi
    Kobayashi, Yohei
    Domei, Takenori
    Soga, Yoshimitsu
    Hyodo, Makoto
    Shirai, Shinichi
    Ando, Kenji
    CIRCULATION JOURNAL, 2017, 81 (04) : 450 - 457
  • [24] Fate of irregular protrusion after second-generation drug-eluting stent implantation: Serial optical coherence tomography study
    Sonoda, Shinjo
    Sanuki, Yoshinori
    Muraoka, Yoshitaka
    Takami, Hironori
    Shimizu, Akiyoshi
    Kitagawa, Megumi
    Tsuda, Yuki
    Araki, Masaru
    Otsuji, Yutaka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B228 - B228
  • [25] Second-Generation Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in Patients With Diabetes
    Schoos, Mikkel M.
    Clemmensen, Peter
    Dangas, George D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 494 - 496
  • [26] The association of diabetes mellitus with neointimal formation following deployment of second-generation drug-eluting stents: an optical coherence tomographic study
    Cai, Jin-Zan
    Lu, Wen-Qi
    Xu, Chen
    Gu, Jue
    You, Wei
    Xu, Tian
    Gogas, Bill D.
    Jia, Hai-Bo
    Ye, Fei
    CORONARY ARTERY DISEASE, 2021, 32 (02) : 105 - 111
  • [27] Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus:a single center study
    Xiaofang Tang
    Jinqing Yuan
    Bo Xu
    中国循环杂志, 2018, (S1) : 135 - 135
  • [28] Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study
    Basavarajaiah, Sandeep
    Naganuma, Toru
    Latib, Azeem
    Sticchi, Alessandro
    Ciconte, Giuseppe
    Panoulas, Vasilis
    Chieffo, Alaide
    Montorfano, Matteo
    Carlino, Mauro
    Colombo, Antonio
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (04) : 522 - 528
  • [29] Delayed Neointimalization on Drug-Eluting Stents - Speculation From Optical Coherence Tomography -
    Shite, Junya
    CIRCULATION JOURNAL, 2009, 73 (12) : 2210 - 2211
  • [30] A propensity score matched analysis to determine if second-generation drug-eluting stents outperform first-generation drug-eluting stents in a complex patient population
    Loh, Joshua P.
    Pendyala, Lakshmana K.
    Kitabata, Hironori
    Badr, Salem
    Torguson, Rebecca
    Chen, Fang
    Satler, Lowell F.
    Suddath, William O.
    Pichard, Augusto D.
    Waksman, Ron
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (01) : 43 - 48
12345